New wound treatment for non-healing foot ulcers
from Diabetes Health
Results are expected by the end of the month in an efficacy study on a new drug that promises to improve diabetic wound care. Derma Sciences is wrapping up work on a phase 2 trial of DSC127, a drug already shown to speed up healing in animal tests. According to Barry Wolfenson, executive vice president of global business development and marketing for the company, the study's last patient came aboard Sept. 27, and the trial was set to wrap by the end of December 2010. After crunching the numbers, the company will be able to say how many patients' wounds were completely healed by the end of the 12-week study period.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063